New 25,000-square-foot state-of-the-art cGMP manufacturing facility in West Sacramento, CA, quadruples manufacturing capacity as the company continues to remain focused on serving the cell and gene therapy market

Regis Technologies, a contract development and manufacturing organization for small molecule active pharmaceutical ingredients, announces a new Solid State Chemistry service.

Regis Technologies, a contract development and manufacturing organization for small molecule active pharmaceutical ingredients, earned perfect results from its April 2019 FDA inspection.

Presentation to highlight the approaches used in developing consistent cell-based potency assays meeting regulatory expectations (USP <1032> and <1033>) and are suitable for CGMP stability testing

Live session on Wednesday, February 21, 2018, discusses how AGC Biologics protein expression system significantly accelerates and improves the biologics production process with rapid timelines, competitive titers, a robust platform, regulatory acceptance, and reliable manufacturing productivity.

If you are affected by the new FDA FSMA law you might be asking yourself "how much is this all going to cost?" The answer is going to surprise you.

Any pharmaceutical worker who must deal with products both in early and latter phases of development should attend this course in order to be aware of the regulatory requirements that will affect operations dealing with these products.

Critical information that dietary supplement manufacturers must know in order to meet the FDA's good manufacturing practices "compliance paradigm" is detailed in a free white paper at http://www.microtestlabs.com/dietarypaper.

Alkemists Labs is pleased to announce that Kelly Reins has joined the company as Executive Director of Laboratory Operations &amp; Compliance.